PDII Stock News 4.69 05/13/2014 14:04:02 Pdi Inc (PDII)

New Post Public Reply Private Reply Replies (0) Message Board

May 13, 2014 at 3:04 PM

Pdi Inc (PDII) 4.69 $PDII

PDI Reports 2014 First Quarter Financial Results
PR Newswire - Wed May 07, 3:30PM CDT
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the first quarter ended March 31, 2014. Summary financial and operational accomplishments include:

PDI, Inc. to Hold First Quarter Financial Results Conference Call on Thursday, May 8, 2014
PR Newswire - Mon Apr 28, 11:09AM CDT
PDI, Inc. (Nasdaq

DII) today announced that it will release its first quarter 2014 financial results on Wednesday, May 7, 2014 after the market close and host a conference call on Thursday, May 8 at 8:30 am Eastern time to discuss the results.

Can PDI (PDII) Continue to Rise? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 8:01AM CDT
Can PDI (PDII) Continue to Rise?

Is PDI (PDII) Ready to Breakout? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:44AM CDT
Is PDI (PDII) Ready to Breakout?

PDI Inc.: A Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 9:30AM CDT
On April 3, 2014, Zacks Investment Research downgraded PDI Inc. to a Zacks Rank #5 (Strong Sell).

Molecular Diagnostics Veteran, Greg Richard, Joins PDI, Inc. as General Manager for Interpace Diagnostics Subsidiary
PR Newswire - Wed Apr 02, 7:45AM CDT
PDI, Inc. (Nasdaq: PDII), a market leader in healthcare product commercialization and integrated marketing services, has hired Greg Richard as General Manager for its Interpace Diagnostics subsidiary. Richard will be responsible for evolving and driving the execution of PDI's molecular diagnostics growth strategy.

Nasdaq stocks posting largest volume increases
AP - Wed Mar 26, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

PDI, Inc. to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference
PR Newswire - Tue Mar 04, 3:05PM CST
PDI, Inc. (Nasdaq: PDII) today announced that Jeff Smith, the company's chief financial officer, is scheduled to present at the ROTH Capital Partners 26th Annual Growth Stock Conference at 4:30 pm PT on March 11, 2014 at the Ritz-Carlton Laguna Nigel in Dana Point, CA.

Q4 Loss Widens at PDI, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 1:18PM CST
PDI Inc.'s fourth quarter loss came in at 25 cents per share, wider than the Zacks Consensus Estimate loss of 11 cents and the year-ago loss of 3 cents.

PDI Reports 2013 Fourth Quarter and Full Year Financial Results
PR Newswire - Thu Feb 27, 3:05PM CST
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the fourth quarter and year ended December 31, 2013. Summary financial and operational accomplishments include:

PDI, Inc. to Hold Fourth Quarter and Full Year 2013 Financial Results Conference Call on Thursday, February 27, 2014
PR Newswire - Tue Feb 18, 3:21PM CST
PDI, Inc. (Nasdaq: PDII) today announced that it will release its fourth quarter 2013 financial results on Thursday, February 27, 2014 after the market close and host a conference call beginning at 5:00 pm Eastern time to discuss the results.

Rentrak (RENT) Jumps: Stock Soars 14.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 20, 8:25AM CST
Rentrak was a big mover last session, with shares rising over 14%.

PDI, Inc. Reinvents Sales Rep And Physician Interaction With New Digital Communications Network
PR Newswire - Tue Jan 14, 7:45AM CST
PDI, Inc. (Nasdaq: PDII), today announced the launch of PD One(TM), a proprietary technology platform aimed at expanding relationships between pharmaceutical and life science manufacturers and health care providers. The subscription-based platform enables clients to extend personal and brand interactions with physicians through a secure, professional networking platform that features direct messaging and dynamic content. PDI also announced that it has contracted with a leading pharmaceutical company to provide PD One to select sales representatives across the U.S., while its own Interpace Diagnostics subsidiary will also launch the platform with its sales force.

Nasdaq stocks posting largest percentage increases
AP - Fri Jan 03, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Wider Fiscal Q2 Loss at JTH Holding - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 10, 9:24AM CST
JTH Holding's fiscal 2014 second-quarter net loss of 66 cents per share was wider than the prior-year quarter loss of 47 cents per share and the Zacks Consensus Estimate of a loss of 57 cents.

In-Line Q3 Loss at Competitive Technologies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 8:10AM CST
Competitive Technologies reported its third-quarter 2013 net loss of 4 cents per share, in line with the Zacks Consensus Estimate. The number also remained unchanged year over year.

PDI Posts Narrower Loss, Revs Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 13, 11:35AM CST
PDI's third-quarter 2013 operating net loss per share of 14 cents was narrower than the Zacks Consensus Estimate of a loss of 23 cents but widened from 6 cents in the year-ago quarter.

PDI Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 12, 3:05PM CST
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the third quarter ended September 30, 2013. Third quarter and subsequent financial and operational accomplishments include:

PDI, Inc. Enters into Collaboration Agreement to Commercialize Molecular Diagnostic Tests
PR Newswire - Tue Aug 20, 6:30AM CDT
PDI, Inc. (Nasdaq: PDII) today announced the signing of a collaboration agreement with a privately held molecular diagnostics company (the Company) to commercialize the Company's molecular diagnostic tests. The initial test to be commercialized is fully developed. For competitive reasons, the name of the company and the specific focus area of the initial test to be commercialized are not being disclosed at this time.

PDI Reports 2013 Second Quarter Financial Results
PR Newswire - Mon Aug 05, 3:01PM CDT
PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the second quarter ended June 30, 2013. Summary financial and operating highlights include:

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

IEHP's Wellness Center Launch Faces Delay in California

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Windward Bio Surges 68% in Nasdaq Debut

By Ryan Hughes Updated Nov 13, 2026 Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

LaserAway Expands to 244 Clinics Over 20 Years

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...